Circulars

Back to Circulars

30 April 2020

Safety Alerts and Recall for Pharmaceutical Products & Medical Devices

Reference: CIR-2020-00000004

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

  • Recall one batch of Pharmaceutical Product Mirtazapine Tablets
  • Safety Alerts for Body Building Product Psychotic
  • Safety Alerts for medical device Intraosseous vascular access needle sets (Arrow EZ-IO)
  • Warning for patients using the products U-Dream herbal sleep-aid tablets U-Dream Lite, U-Dream Half-Night & U-Dream Full Night
  • Voluntary Recall for specific lots of medical device Bard MaxCore Disposable Core Biopsy Instrument
  • Warning for patients using the products gabapentin and pregabalin
  • Safety alerts for use of unauthorized skin products

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Recall one batch of Pharmaceutical Product Mirtazapine Tablets.pdf:

View Document

Safety Alerts for Body Building Product Psychotic.pdf:

View Document

Safety Alerts for medical device Intraosseous vascular access needle sets (Arrow EZ-IO).pdf:

View Document

U-Dream herbal sleep-aid tablets U-Dream Lite U-Dream Half-Night U-Dream Full Night.pdf:

View Document

Voluntary Recall for specific lots of medical device Bard MaxCore Disposable Core Biopsy Instrument.pdf:

View Document

Warning for patients using the products gabapentin and pregabalin.pdf:

View Document

Safety alerts for use of unauthorized skin products.pdf:

View Document

Close